$6.96 0.08 (+1.16%)
11/23/2009 3:37 PM

MannKind Corp (MNKD)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Featured Broker Partners